In this issue:
Patient-reported outcomes with nivolumab + cabozantinib in advanced RCC
Nivolumab + ipilimumab for advanced RCC with brain metastases
Machine learning pathomics signature for clear cell RCC
Risk factors for recurrence in patients with pT1a RCC
Exposure-response analyses of cabozantinib for mRCC
Surgical outcomes in older patients with RCC and IVC thrombus
Dual tracer PSMA + FDG PET/CT in RCC
Effects of race and socioeconomic status on treatment for localised renal masses
Off-clamp robot-assisted partial nephrectomy
Extended disease control with cabozantinib dose increase in mRCC
Please login below to download this issue (PDF)